At LSI 2021, Philip D. Rackliffe, CEO of Centerline Biomedical sits down with Benjamin Glenn of A Matter of Innovation to discuss Centerline Biomedical's new Endovascular Navigation Technology, the powerful story behind the technology's origins, huge advances in the mitigation of radiation exposure during OR time, inspiring tales of surgical successes and the great benefits of developing innovation in the Heartland. AMOI Website
Benjamin Glenn is nationally recognized innovation strategist, speaker and coach based in the Silicon Valley. His work is keenly focused on helping entrepreneurs and innovators in enterprises big and small in our regulated industries identify, develop and maintain competitive advantages. Particularly with regard to our rapidly evolving health care sector, Benjamin's work is highlighted in Biodesign: The Process of Innovating Medical Technologies, a program he has served for over a decade.
Benjamin strongly believes in the increasing importance, and even the necessity, of creating and training a while array of multi-disciplinary teams. Benjamin's passionate presentations often focus on how professionals from different disciplines can successfully work together to create the products and services of the modern economy.
In his presentations, Benjamin draws on his diverse experiences growing up in Texas, serving in the military and working as a Silicon Valley patent attorney. His unique, humorous and often metaphor-ladened insights also draw from over two decades of advising clients on strategic, commercial, innovation and product development issues. As a result, his engaging style has inspired and entertained audiences at leading innovation and entrepreneurial programs nationwide including:
Stanford University BioDesign Program, UC San Francisco, Johns Hopkins University and Northwestern University, along with accelerator and incubator programs such as Matter Chicago, Texas Medical Center’s TMCx, South By SouthWest, VentureWell, Village Capital, Kauffman Foundation, Singularity University, and MedTech Innovator.
Benjamin Glenn is nationally recognized innovation strategist, speaker and coach based in the Silicon Valley. His work is keenly focused on helping entrepreneurs and innovators in enterprises big and small in our regulated industries identify, develop and maintain competitive advantages. Particularly with regard to our rapidly evolving health care sector, Benjamin's work is highlighted in Biodesign: The Process of Innovating Medical Technologies, a program he has served for over a decade.
Benjamin strongly believes in the increasing importance, and even the necessity, of creating and training a while array of multi-disciplinary teams. Benjamin's passionate presentations often focus on how professionals from different disciplines can successfully work together to create the products and services of the modern economy.
In his presentations, Benjamin draws on his diverse experiences growing up in Texas, serving in the military and working as a Silicon Valley patent attorney. His unique, humorous and often metaphor-ladened insights also draw from over two decades of advising clients on strategic, commercial, innovation and product development issues. As a result, his engaging style has inspired and entertained audiences at leading innovation and entrepreneurial programs nationwide including:
Stanford University BioDesign Program, UC San Francisco, Johns Hopkins University and Northwestern University, along with accelerator and incubator programs such as Matter Chicago, Texas Medical Center’s TMCx, South By SouthWest, VentureWell, Village Capital, Kauffman Foundation, Singularity University, and MedTech Innovator.
• 25 years of global healthcare leadership and executive management in medical device, medical technology and pharmaceutical industries spanning public and private sectors
• Successfully grew and scaled companies from start-ups to large multi-nationals, raised millions in capital and bought/sold assets totaling over $1B in proceeds
• General management and P&L ownership from start-ups to company divisions with over $2 billion in annual revenue
• Corporate leadership roles across strategy, sales, marketing (upstream and downstream), business development, operations and global franchises
• Launched more than 50 life sciences products that span both medical device and pharmaceutical sectors
• Keen focus on building strong team cultures by employing a diverse workforce and valuing inclusion at all levels of the organization
• Significant experience in M&A by acquiring and divesting businesses to help drive business synergies
• Extensive international business experience across developed and emerging markets; leading and closing deals in the US, Europe, India, China, Taiwan, Korea and Brazil
• Proven influence capabilities to advance complex business initiatives across a matrixed organization
• Competitive leader that constantly seeks to maximize value for patients and shareholders
• Strong customer intimacy skills gained from starting as a sales professional
• Proud father of two high school aged children, a practicing physician wife and avid tennis player
• 25 years of global healthcare leadership and executive management in medical device, medical technology and pharmaceutical industries spanning public and private sectors
• Successfully grew and scaled companies from start-ups to large multi-nationals, raised millions in capital and bought/sold assets totaling over $1B in proceeds
• General management and P&L ownership from start-ups to company divisions with over $2 billion in annual revenue
• Corporate leadership roles across strategy, sales, marketing (upstream and downstream), business development, operations and global franchises
• Launched more than 50 life sciences products that span both medical device and pharmaceutical sectors
• Keen focus on building strong team cultures by employing a diverse workforce and valuing inclusion at all levels of the organization
• Significant experience in M&A by acquiring and divesting businesses to help drive business synergies
• Extensive international business experience across developed and emerging markets; leading and closing deals in the US, Europe, India, China, Taiwan, Korea and Brazil
• Proven influence capabilities to advance complex business initiatives across a matrixed organization
• Competitive leader that constantly seeks to maximize value for patients and shareholders
• Strong customer intimacy skills gained from starting as a sales professional
• Proud father of two high school aged children, a practicing physician wife and avid tennis player
At LSI 2021, Philip D. Rackliffe, CEO of Centerline Biomedical sits down with Benjamin Glenn of A Matter of Innovation to discuss Centerline Biomedical's new Endovascular Navigation Technology, the powerful story behind the technology's origins, huge advances in the mitigation of radiation exposure during OR time, inspiring tales of surgical successes and the great benefits of developing innovation in the Heartland. AMOI Website
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy